Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression (2021)
Attributed to:
ZMYND8-regulation of MITF as potential therapeutic target in melanoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3929/ethz-b-000494403
Publication URI: http://hdl.handle.net/20.500.11850/494403
Type: Other